Disclosure of holding in IDEX

IDEX ASA (“IDEX”) issues this notice on behalf of Woodford Investment Management LLP (“Woodford”) acting as agent for and on behalf of CF Woodford Equity Income fund, Old Mutual Woodford Equity Income fund and Woodford Patient Capital Trust.

Reference is made to the announcement by IDEX on 26 March 2015 that funds managed by Woodford had agreed to invest NOK 296.6 million in IDEX, with the possibility of additional investment by exercise of warrants. The investment was subject to approval by an extraordinary general meeting of shareholders in IDEX, which meeting was held on 29 April 2015 and approved the issue of shares and warrants.

Following the extraordinary general meeting and IDEX’s fulfillment of other conditions, CF Woodford Equity Income fund, Old Mutual Woodford Equity Income fund and Woodford Patient Capital Trust have subscribed for shares and warrants.

The share capital of IDEX will consist of 469,120,224 shares after the share issue.

CF Woodford Equity Income fund, Old Mutual Woodford Equity Income fund and Woodford Patient Capital Trust have combined subscribed for 52,500,000 shares, and control 11.2 per cent of the issued share capital and votes in IDEX. CF Woodford Equity Income fund, Old Mutual Woodford Equity Income fund and Woodford Patient Capital Trust have combined also subscribed for 26,250,000 warrants, thereby holding a combined number of shares and warrants of 78,750,000 shares and warrants, which represent 16.8 per cent of the issued shares in IDEX.

The warrants are exercisable at any time between 29 April 2016 and 29 April 2017 whereafter they expire and will not be exercisable.

7 May 2015
IDEX ASA

 
 
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

FACEBOOK
GOOGLE
TWITTER
LINKEDIN